Literature DB >> 8449677

Variable oxygen exposure causes preretinal neovascularization in the newborn rat.

J S Penn1, B L Tolman, L A Lowery.   

Abstract

PURPOSE: To test the hypothesis that variable hyperoxia potentiates preretinal neovascularization in newborn rats, and to establish a more reliable animal model of ROP in which therapies designed to inhibit abnormal angiogenesis can be tested.
METHODS: Immediately after birth, litters of Sprague Dawley albino rats and mothers were placed in an incubator containing 40% oxygen. After 12 hours, the oxygen was increased to 80% with a transition time of less than 1 min. For the ensuing 7, 10, or 14 days, the oxygen was altered between 40% and 80% every 12 hr in a stepwise fashion. Other litters were kept in constant 80% oxygen or in room air for the same three time periods. After exposure, rats were either killed or placed in room air for an additional 2, 4, or 7 days before being killed.
RESULTS: When rats were killed immediately after oxygen exposure, the resulting vessel loss in rats exposed to 40%/80% oxygen was identical to that of animals exposed to 80% (vessels constituted 12.2 +/- 2.2% of total retinal area in cyclic oxygen vs 12.0 +/- 1.2% in constant oxygen). However, preretinal neovascularization subsequently occurred in 66% (63/96) of all rats exposed to cyclic oxygen followed by a room air period but in no rats (0/50) exposed to constant oxygen followed by room air. Preretinal vascular proliferation consisted of glomerular tufts of endothelial cells, or mature, lumenized vessels containing red blood cells.
CONCLUSIONS: Consistency of oxygen therapy is more important than overall oxygen level in inducing retinopathy. Consideration should be given to tighter control of intended oxygen therapy in premature infants, regardless of the target saturation level.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449677

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  69 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

2.  Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.

Authors:  Joshua M Barnett; Sandra Suarez; Gary W McCollum; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

3.  Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.

Authors:  Joshua M Barnett; Gary W McCollum; Jessica A Fowler; James J-W Duan; Jesse D Kay; Rui-Qin Liu; David P Bingaman; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

4.  The role of PGE2 receptor EP4 in pathologic ocular angiogenesis.

Authors:  Susan E Yanni; Joshua M Barnett; Monika L Clark; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-03       Impact factor: 4.799

5.  The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.

Authors:  Grace Byfield; Steve Budd; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

Review 6.  Retinopathy of prematurity.

Authors:  Ann Hellström; Lois E H Smith; Olaf Dammann
Journal:  Lancet       Date:  2013-06-17       Impact factor: 79.321

Review 7.  Hereditary influences in oxygen-induced retinopathy in the rat.

Authors:  Peter van Wijngaarden; Helen M Brereton; Douglas J Coster; Keryn A Williams
Journal:  Doc Ophthalmol       Date:  2009-09-19       Impact factor: 2.379

Review 8.  Ocular neovascularization: clarifying complex interactions.

Authors:  K A Neely; T W Gardner
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

9.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

10.  Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

Authors:  Yuta Saito; Abhineet Uppal; Grace Byfield; Steven Budd; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.